LifeMD, Inc. — Director's Dealing 2018

May 2, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-16

Reporting Person: Bruzzese Anthony (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01	1059761	Direct
Common Stock, par value $0.01	130000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to purchase Common Stock	$0.20	2021-12-31	Common Stock (560000)		Direct
Option to purchase Common Stock	$0.10	2018-09-30	Common Stock (40800)		Direct
Option to purchase Common Stock	$0.35	2027-07-01	Common Stock (100000)		Direct
Option to purchase Common Stock	$0.40	2021-04-20	Common Stock (250000)		Direct

Footnotes

F1: The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.